Researchers discover antitumor molecule that originated within oncogene

June 5, 2012

A common point in all human tumors is that they produce an activation of oncogenes, genes that cause cancer and they also cause a loss of function of the protective genes, called anti-oncogenes or tumour suppressor genes. Normally both categories of anticancer and procancer genes are in different regions of our chromosomes.

A study coordinated by Manel Esteller, Director of the program of epigenetics and at the Bellvitge Institute for Biomedical Research (IDIBELL), Professor of genetics at the University of Barcelona and ICREA researcher, has discovered the existence of an antitumor molecule that originates within an oncogene. The finding is published this week in the Nature Structural & Molecular Biology journal.

The identified anti-oncogene is along non-coding ribonucleic acid (lncRNA), ie a molecule that does not produce protein itself but is responsible for regulating the expression of other proteins. Specifically, the identified molecule is produced in a cancer-causing gene (SMYD3) as its role in healthy cells is to inhibit pro-cancer action of the .

If you enter this fragment of ribonucleic acid on cancer cells growing in laboratory or in human tumors implanted in animals for research is able to block cancer growth. "We believe this discovery will be the starting point to find many other oncogenes and anti-oncogenes that coexist in regions of our genome, that when their life together deteriorates, contribute to the development of human tumors," said Dr. Esteller.

Explore further: Researchers discover a substance against the 'dark genome' of cancer

More information: Intronic RNAs mediate EZH2 regulation of epigenetic targets. Sònia Guil, Marta Soler, Anna Portela, Jordi Carrère, Elena Fonalleras, Antonio Gómez, Alberto Villanueva and Manel Esteller. Nature Structural & Molecular Biology, Early Edition, May 21, 2012.

Related Stories

Researchers complete the first epigenome in Europe

May 30, 2012

A study led by Manel Esteller, director of the Epigenetics and Cancer Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), professor of genetics at the University of Barcelona and ICREA researcher, has ...

Why cancer cells change their appearance?

September 2, 2011

Like snakes, tumour cells shed their skin. Cancer is not a static disease but during its development the disease accumulates changes to evade natural defences adapting to new environmental circumstances, protecting against ...

Recommended for you

Energy-saving LEDs boost light pollution worldwide

November 22, 2017

They were supposed to bring about an energy revolution—but the popularity of LED lights is driving an increase in light pollution worldwide, with dire consequences for human and animal health, researchers said Wednesday.

Re-cloning of first cloned dog deemed successful thus far

November 22, 2017

(Phys.org)—A team of researchers with Seoul National University, Michigan State University and the University of Illinois at Urbana-Champaign has re-cloned the first dog to be cloned. In their paper published in the journal ...

Testing the advantage of being left-handed in sports

November 22, 2017

(Phys.org)—Sports scientist Florian Loffing with the Institute of Sport Science, University of Oldenburg in Germany has conducted a study regarding the possibility of left-handed athletes having an advantage over their ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.